Genetic dissection of vasculitis, myeloperoxidase-specific antineutrophil cytoplasmic autoantibody production, and related traits in spontaneous crescentic glomerulonephritis-forming/Kinjoh mice

Journal of Immunology

Volumn 176, Issue 6, 2006, Pages 3662-3673

  Hamano, Yoshitomo ^a   Tsukamoto, Kazuyuki ^a   Abe, Masaaki ^a   Sun, Guo Dong ^a   Zhang, Danqing ^a   Fujii, Hiroaki ^a   Matsuoka, Shuji ^a   Tanaka, Masumi ^a   Ishida Okawara, Akiko ^b   Tachikawa, Hitoshi ^b   Nishimura, Hiroyuki ^c   Tokunaka, Kazuhiro ^d   Hirose, Sachiko ^a   Suzuki, Kazuo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c TOIN UNIVERSITY OF YOKOHAMA   (Japan)

^d NIPPON KAYAKU CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ANCA ASSOCIATED VASCULITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTROMERE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 4; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 8; CONTROLLED STUDY; FAS GENE; GENE; GENE FUNCTION; GENE MAPPING; GENE MUTATION; GENETIC PREDISPOSITION; HYPERGAMMAGLOBULINEMIA; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SPLENOMEGALY;

EID: 33644839422     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.6.3662     Document Type: Article

References (57)

1. Kinjoh, K., M. Kyogoku, and R. A. Good. 1993. Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis. Proc. Natl. Acad. Sci. USA 90: 3413-3417.
2. Miyazawa, S., K. Saiga, K. Nemoto, T. Mae, and O. Hotta. 2002. A repeat biopsy study in spontaneous crescentic glomerulonephritis mice. Ren. Fail. 24: 557-566.
3. Jennette, J. C., and R. J. Falk. 1994. The pathology of vasculitis involving the kidney. Am. J. Kidney Dis. 24: 130-141.
4. Ishida-Okawara, A., T. Ito-Ihara, E. Muso, T. Ono, K. Saiga, K. Nemoto, and K. Suzuki. 2004. Neutrophil contribution to the crescentic glomerulonephritis in SCG/Kj mice. Nephrol. Dial. Transplant. 19: 1708-1715.
5. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity I: 219-229.
6. Wang, Y., M. Nose, T. Kamoto, M. Nishimura, and H. Hiai. 1997. Host modifier genes affect mouse autoimmunity induced by the lpr gene. Am. J. Pathol. 151: 1791-1798.
7. 2 mice. J. Immunol. 171: 6442-6447.
8. Knight, J. G., D. D. Adams, and H. D. Purves. 1977. The genetic contribution of the NZB mouse to the renal disease of the NZB × NZW hybrid. Clin. Exp. Immunol. 28: 352-358.
9. Bates, D. L., P. J. Butler, E. C. Pearson, and J. O. Thomas. 1981. Stability of the higher order structure of chicken-erythrocyte chromatin in solution. Eur. J. Biochem. 119: 469-476.
10. Jiang, Y., S. Hirose, M. Abe, R. Sanokawa-Akakura, M. Ohtsuji, X. Mi, N. Li, Y. Xiu, D. Zhang, J. Shirai, et al. 2000. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 51: 429-435.
11. Churchill, G. A., and R. W. Doerge. 1994. Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971.
12. Nose, M., M. Nishimura, and M. Kyogoku. 1989. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes: the use of mouse genetics to dissociate the development of arteritis and glomerulonephritis. Am. J. Pathol. 135: 271-280.
13. Hogarth, M. B., J. H. Slingsby, P. J. Allen, E. M. Thompson, P. Chandler, K. A. Davies, E. Simpson, B. J. Morley, and M. J. Walport. 1998. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J. Immunol. 161: 2753-2761.
14. Lander, E. S., and D. Botstein. 1989. Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121: 185-199.
15. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91: 10168-10172.
16. Vyse, T. J., S. J. Rozzo, C. G. Drake, S. Izui, and B. L. Kotzin. 1997. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. J. Immunol. 158: 5566-5574.
17. Haywood, M. E., M. B. Hogarth, J. H. Slingsby, S. J. Rose, P. J. Allen, E. M. Thompson, M. A. Maibaum, P. Chandler, K. A. Davies, E. Simpson, et al. 2000. Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice. Arthritis Rheum. 43: 349-355.
18. Morel, L., and E. K. Wakeland. 2000. Lessons from the NZM2410 model and related strains. Int. Rev. Immunol. 19: 423-446.
19. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178.
20. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976.
21. Irving, B. A., and A. Weiss. 1991. The cytoplasmic domain of the T cell receptor ζ-chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64: 891-901.
22. Tsuzaka, K., I. Fukuhara, Y. Setoyama, K. Yoshimoto, K. Suzuki, T. Abe, and T. Takeuchi. 2003. TCR ζ mRNA with an alternatively spliced 3′-untranslated region detected in systemic lupus erythematosus patients leads to the down-regulation of TCR zeta and TCR/CD3 complex. J. Immunol. 171: 2496-2503.
23. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19: 275-290.
24. Takai, T. 2002. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2: 580-592.
25. Pritchard, N. R., A. J. Cutler, S. Uribe, S. J. Chadban, B. J. Morley, and K. G. Smith. 2000. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII. Curr. Biol. 10: 227-230.
26. Yajima, K., A. Nakamura, A. Sugahara, and T. Takai. 2003. FcγRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease. Em. J. Immunol. 33: 1020-1029.
27. Li, X., J. Wu, R. H. Carter, J. C. Edberg, K. Su, G. S. Cooper, and R. P. Kimberly. 2003. A novel polymorphism in the Fcγ receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum. 48: 3242-3252.
28. Okuda, K., A. Kanamaru, E. Ueda, T. Kitani, and K. Nagai. 1990. Membrane expression of decay-accelerating factor on neutrophils from normal individuals and patients with paroxysmal nocturnal hemoglobinuria. Blood 15: 1186-1191.
29. Berger, M., and M. E. Medof. 1987. Increased expression of complement decay-accelerating factor during activation of human neutrophils. J. Clin. Invest. 79: 214-220.
30. Brubaker, L. H., L. J. Essig, and C. E. Mengel. 1977. Neutrophil lifespan in paroxysmal nocturnal hemoglobinuria. Blood 50: 657-662.
31. Yu, H., F. Maurer, and R. L. Medcalf. 2002. Plasminogen activator inhibitor type 2: a regulator of monocyte proliferation and differentiation. Blood 99: 2810-2818.
32. Gan, H., G. W. Newman, and H. G. Remold. 1995. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J. Immunol. 155: 1304-1315.
33. Costelloe, E. O., K. J. Stacey, T. M. Antalis, and D. A. Hume. 1999. Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages: demonstration of a novel pattern of responsiveness to bacterial endotoxin. J. Leukocyte Biol. 66: 172-182.
34. Haj, M. A., L. A. Robbie, G. D. Adey, and B. Bennett. 1995. Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients. Thromb. Haemost. 74: 1528-1532.
35. Gu, L., A. Weinreb, X. P. Wang, D. J. Zack, J. H. Qiao, R. Weisbart, and A. J. Lusis. 1998. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J. Immunol. 161: 6999-7006.
36. Jandl, R. C., J. L. George, C. A. Dinarello, and P. H. Schur. 1987. The effect of interleukin 1 on IgG synthesis in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 45: 384-394.
37. Kikuchi, S., L. Fossati-Jimack, T. Moll, H. Amano, E. Amano, A. Ida, N. Ibnou-Zekri, C. Laporte, M. L. Santiago-Raber, S. J. Rozzo, et al. 2005. Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis. J. Immunol. 174: 1111-1117.
38. lpr mice. J. Clin. Invest. 101: 696-702.
39. Lajaunias, F., A. Ida, S. Kikuchi, L. Fossati-Jimack, E. Martinez-Soria, T. Moll, C. L. Law, and S. Izui. 2003. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus. Arthritis Rheum. 48: 1612-1621.
40. Nazareth, M., P. Fanti, C. Schwach, K. Poppenberg, K. Janis, and S. M. Aronica. 2001. Altered Bax expression and decreased apoptosis in bone marrow cells of lupus-susceptible NZB/W mice. Lupus 10: 785-793.
41. Haywood, M. E., T. J. Vyse, A. McDermott, E. M. Thompson, A. Ida, M. J. Walport, S. Izui, and B. J. Morley. 2001. Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone BXSB mice. J. Immunol. 167: 1728-1733.
42. Yoshiki, T., R. C. Mellors, M. Strand, and J. T. August. 1974. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J. Exp. Med. 140: 1011-1027.
43. Hara, I., S. Izui, P. J. McConahey, J. H. Elder, F. C. Jensen, and F. J. Dixon. 1981. Induction of high serum levels of retroviral env gene products (gp70) in mice by bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA 78: 4397-4401.
44. Drake, C. G., S. K. Babcock, E. Palmer, and B. L. Kotzin. 1994. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW)F1 mice. Proc. Natl. Acad. Sci. USA 91: 4062-4066.
45. 1 mice. Eur. J. Immunol. 28: 2694-2703.
46. Kono, D. H., M. S. Park, and A. N. Theofilopoulos. 2003. Genetic complementation in female (BXSB × NZW)F2 mice. J. Immunol. 171: 5442-5447.
47. Qu, W. M., T. Miyazaki, M. Terada, L. M. Lu, M. Nishihara, A. Yamada, S. Mori, Y. Nakamura, H. Ogasawara, C. Yazawa, et al. 2000. Genetic dissection of vasculitis in MRL/lpr lupus mice: a novel susceptibility locus involving the CD72c allele. Eur. J. Immunol. 30: 2027-2037.
48. Nishihara, M., M. Terada, J. Kamogawa, Y. Ohashi, S. Mori, S. Nakatsuru, Y. Nakamura, and M. Nose. 1999. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance. Arthritis Rheum. 42: 2616-2623.
49. Ronnblom, L., M. L. Eloranta, and G. V. Alm. 2003. Role of natural interferon-α producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 36: 463-472.
50. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59.
51. Morita, C., T. Horiuchi, H. Tsukamoto, N. Hatta, Y. Kikuchi, Y. Arinobu, T. Otsuka, T. Sawabe, S. Harashima, K. Nagasawa, and Y. Niho. 2001. Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum. 44: 2819-2827.
52. Sutmuller, M., H. J. Baelde, S. Ouellette, E. De Heer, and J. A. Bruijn. 1998. T-cell receptor Vβ gene expression in experimental lupus nephritis. Immunology 95: 18-25.
53. Massengill, S. F., M. M. Goodenow, and J. W. Sleasman. 1998. SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells. Am. J. Kidney Dis. 31: 418-426.
54. Merino, R., L. Fossati, M. Lacour, R. Lemoine, M. Higaki, and S. Izui. 1992. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur. J. Immunol 22: 295-299.
55. b molecules. Eur. J. Immunol. 26: 307-314.
56. Nakashima, H., H. Inoue, M. Akahoshi, Y. Tanaka, K. Yamaoka, E. Ogami, S. Nagano, Y. Arinobu, H. Niiro, T. Otsuka, and Y. Niho. 1999. The combination of polymorphisms within interferon-γ receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett. 453: 187-190.
57. Mountz, J. D., and A. D. Steinberg. 1989. Studies of c-myb gene regulation in MRL-lpr/lpr mice: Identification of a 5′ c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells. J. Immunol. 142: 328-335.